Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins: Melanoma trials
The registry lists 10 Melanoma studies with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor. 0 are open to participants now and 0 have results posted.
Early Phase 1 1Phase 1 3Phase 2 2Phase 3 1No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Proton Pencil Beam Scanning GRID for Treatment of Bulky TumorsActive, not recruitingNCT05121545Not applicable
- SBRT as a Vaccination for Metastatic MelanomaWithdrawnNCT04042506Phase 2
- SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or SpineCompletedNCT02716948Phase 1
- Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant MelanomaWithdrawnNCT02427893Phase 3
- SRS (Stereotactic Radiosurgery) Plus IpilimumabTerminatedNCT01950195Phase 1
- Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected MelanomaCompletedNCT01435499Phase 1
- Using High Resolution Function Imaging To Detect Melanoma and Dysplastic NeviCompletedNCT01118832
- Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
- Melanoma Biomarker StudyCompletedNCT00348088
- Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye MelanomaCompletedNCT00003802Phase 2